papaverine and prednisone

papaverine has been researched along with prednisone in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Almici, C; Lazzaroni, G1
RITTER, U1
Ben-David, J; Fradis, M; Luntz, M; Magamsa, I; Podoshin, L; Sabo, E1

Reviews

1 review(s) available for papaverine and prednisone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for papaverine and prednisone

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
[Drug therapy of acute cerebral ischemia. Clinical study].
    Giornale di clinica medica, 1974, Volume: 55, Issue:12

    Topics: Brain; Dextrans; Dihydroergotoxine; Ergoloid Mesylates; Humans; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Ischemia; Lidocaine; Papaverine; Prednisone

1974
[DIAGNOSIS AND TREATMENT OF PANCREATITIS].
    Die Medizinische Welt, 1963, Dec-14, Volume: 50

    Topics: Amylases; Anti-Bacterial Agents; Antibiotics, Antitubercular; Atropine; Chyle; Clinical Enzyme Tests; Dermatologic Agents; Diagnosis; Humans; Hypertension; Norepinephrine; Pancreatitis; Papaverine; Prednisolone; Prednisone; Strophanthins

1963
Tinnitus as a prognostic sign in idiopathic sudden sensorineural hearing loss.
    The international tinnitus journal, 2001, Volume: 7, Issue:1

    Topics: Adult; Aged; Audiometry; Auditory Threshold; Dextrans; Female; Glucocorticoids; Hearing Loss, Sudden; Humans; Male; Middle Aged; Papaverine; Plasma Substitutes; Prednisone; Prognosis; Prospective Studies; Risk Factors; Time Factors; Tinnitus; Vasodilator Agents

2001